Armen Haroutunian, MD
Pain Medicine · Westlake Village, CANPI 1588041412
Payments from drug & device makers
Across 427 payments — averaging $335.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Nalu Medical, Inc.$134K
- Boston Scientific$4K
- Abbott$1K
- SPR Therapeutics, Inc$914
- Medtronic$889
- Nevro Corp.$865
- plus $1K from 15 others
What the payments were for
- Consulting fees$113,52279%
- Travel & lodging$14,06810%
- Food & beverage$15,44211%
- Education$280%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Nalu Medical, Inc. | 219 | $134,098 |
| Boston Scientific | 60 | $3,542 |
| Abbott | 48 | $1,344 |
| SPR Therapeutics, Inc | 13 | $914 |
| Medtronic | 28 | $889 |
| Nevro Corp. | 17 | $865 |
| Painteq LLC | 10 | $254 |
| Merz North America, Inc. | 2 | $211 |
| Saluda Medical Americas, Inc. | 5 | $186 |
| Avanos Medical | 1 | $140 |
| Vertiflex, Inc. | 4 | $140 |
| Collegium Pharmaceutical, Inc. | 7 | $100 |
| Sonex Health, Inc. | 1 | $84 |
| Globus Medical | 3 | $80 |
| Biotronik NRO, Inc. | 1 | $48 |
| Biohaven Pharmaceuticals, Inc. | 2 | $44 |
| Kowa Pharmaceuticals America, Inc. | 2 | $41 |
| Vertex | 1 | $27 |
| Intercept Pharmaceuticals, Inc. | 1 | $18 |
| Ipsen Biopharmaceuticals, Inc | 1 | $18 |
| AbbVie | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Nalu Neurostimulation System$130,672
- GENERAL PAIN MANAGEMENT$1,195
- SPRINT PNS System$676
- SUPERION$289
- Omnia$257
- VANTA ADAPTIVESTIM$160
- IonicRF$153
- INTELLIS ADAPTIVESTIM$152
- GENERATOR$140
- S-Series SCS Leads$133
- VERTIFLEX SUPERION$119
How this compares
$143,060 in reported general payments places this provider in the 95th percentile of 840 pain medicine providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 432 | $4,168 |
| Buprenorphine | 14 | $3,657 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 178 | $2,758 |
| Celecoxib | 95 | $2,656 |
| Pregabalin | 106 | $1,523 |
| Lidocaine | 15 | $1,128 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 53 | $1,029 |
| Oxycodone Hcl | 58 | $1,015 |
| Tramadol Hcl | 177 | $1,000 |
| Methocarbamol | 106 | $981 |
| Cyclobenzaprine Hcl | 54 | $888 |
| Baclofen | 46 | $886 |
| Duloxetine Hcl | 36 | $734 |
| Buprenorphine Hcl | 24 | $705 |
| Meloxicam | 103 | $579 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Westlake Village
- Eric GrigsbyNapa$3.2M
- Jason PopeSanta Rosa$2.8M
- Javid GhandehariSanta Monica$2.7M
- Alexander HerselThousand Oaks$2.1M
- Krishnan ChakravarthyTemecula$1.9M
- Kasra AmirdelfanWalnut Creek$1.7M
- Ramana NaiduLarkspur$1.6M
- Foead GeulaStudio City$1.3M
- Xiang QianRedwood City$941K
- Jacqueline WeisbeinNapa$863K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.